Nasdaq Gains Over 100 Points; US Retail Sales Beat Estimates

Cuprina Holdings (Cayman) Limited Announces Closing of Public Offering

Cuprina Holdings (Nasdaq: CUPR), a biomedical company focused on chronic wounds, infertility, medical waste recycling, and cosmeceuticals, closed its public offering of 4.32 million Class A Ordinary Shares at $1.15 per share, raising approximately $4.97 million in gross proceeds. The company plans to use net proceeds for R&D expansion, new market entry, brand building, and infrastructure investment. The offering follows FDA 510(k) clearance for MEDIFLY Maggots™ in June.

Crude Oil Down Over 3%; US Business Inventories Surge In July

U.S. stocks mixed: Dow slipped 0.1%, Nasdaq rose 0.7%, S&P 0.3%; tech led gains, energy fell, while oil dropped 3.2%.

Cuprina Holdings shares are trading lower after the company announced pricing of $4.97 million public offering.

Delixy Holdings shares are trading lower after the company announced a 1-for-5 reverse stock split.

Delixy Holdings Announces 1-For-5 Reverse Stock Split, Effective September 28

As a result of the Reverse Share Split, each five (5) issued and outstanding Class A Ordinary Shares will be combined into one (1) Class A Ordinary Share, and each five (5) issued and outstanding Class B Ordinary Shares

Why Alaunos Therapeutics Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

Alaunos rose 21.8% after adopting amended bylaws; Cheetah Net led gainers, while Xenon dropped 27.6% after pausing study enrollment.